Insider Sales Raise Valuation Questions at J&J, TSMC

At Johnson & Johnson, the stock has climbed to about $263.40 from roughly $211.82 in mid-December, while still trading well above both its 50-day and 200-day moving averages. The shares have also cooled from a recent stretch that pushed the relative strength index into overheated territory. That kind of backdrop often encourages insider sales through prearranged plans and portfolio diversification, but it also raises questions about how much upside is already priced into a mature healthcare franchise.

TSMC’s move is more complicated. Its shares remain up sharply over the past year, but the recent pullback to about $403.41 from a late-June high above $477 has taken some momentum out of the name. The stock is now below its 50-day moving average and its RSI has fallen into oversold territory, suggesting investors have already started to de-rate the stock after a strong run. Against that backdrop, board and executive shareholding changes disclosed in a July filing are likely to be read less as a fundamental warning than as another reminder that even elite chip manufacturers are not immune to profit-taking after a rally.

For investors, the immediate implication is not that insider selling is a reliable sell signal. In many cases, especially at large-cap companies, disposals are tied to tax planning, diversification or 10b5-1 programs, and insiders may still retain sizable stakes. But clustered sales after substantial gains can still matter because they temper the narrative that every breakout is being validated by management conviction. That is especially true when sentiment across the market is fragile, with Adalytica’s S&P 500 trade signals showing fear and extreme caution around the broader index.

The bullish case remains intact for both companies. Johnson & Johnson still offers defensive earnings quality, scale and a balance-sheet profile that tends to attract capital when growth names wobble. TSMC remains the critical manufacturing gatekeeper for advanced semiconductors and AI infrastructure, with long-term demand still tied to high-performance computing and leading-edge node adoption. The bearish case is that both stocks have already moved far enough that the next leg higher will need cleaner earnings execution, not just multiple expansion.

What investors should watch next is whether these sales remain isolated, whether more insiders follow suit after the latest share-price strength, and whether earnings can justify the valuations implied by the recent rallies. If they do, the trades will fade into the background. If not, they may be remembered as an early sign that the market’s strongest names were beginning to meet resistance.